Table 4.
Adverse events.
| Adverse events | All grades | Grade 3 or worse |
|---|---|---|
| Nausea | 11 (25.0) | 0 (0) |
| Fatigue | 12 (27.3) | 0 (0) |
| Weight loss | 3 (6.8) | 0 (0) |
| Diarrhea | 4 (9.1) | 0 (0) |
| Urinary infection | 2 (4.5) | 0 (0) |
| Anemia | 16 (36.4) | 2 (4.5) |
| Leukopenia | 20 (45.5) | 2 (4.5) |
| Neutropenia | 21 (47.7) | 4 (9.1) |
| Thrombocytopenia | 15 (34.1) | 1 (2.3) |
| Hyperglycemia | 14 (31.8) | 0 (0) |
| Increased alanine aminotransferase | 9 (20.5) | 1 (2.3) |
| Increased aspartate aminotransferase | 11 (25.0) | 2 (4.5) |
| Increased transpeptidase | 17 (38.6) | 4 (9.1) |
| Hypoproteinemia | 18 (40.9) | 0 (0) |
| Hypokalemia | 11 (25.0) | 1 (2.3) |
| Hypocalcemia | 10 (22.7) | 0 (0) |
| Hypophosphatemia | 8 (18.2) | 0 (0) |
| Hypertriglyceridemia | 5 (11.4) | 0 (0) |